301847-72-3

Upstream product

• 301847-37-0 Org 41841 
• 1700-37-4 3-Benzyloxybenzaldehyde 
• 898254-60-9 4-(3-(benzyloxy)phenyl)-5-carbonitrile-6-chloro-2-(methylthio)pyrimidine 
• 898254-55-2 4-(3-(benzyloxy)phenyl)-5-carbonitrile-1,6-dihydro-2-(methylthio)-6-oxopyrimidine 
• 898254-65-4 N-tert-butyl-5-amino-4-(3-(benzyloxy)phenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide 
• 898254-64-3 ethyl 5-amino-4-(3-(benzyloxy)phenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxylate 
• 898254-69-8 5-amino-4-(3-benzyloxy-phenyl)-2-methylsulfanyl-thieno[2,3-d]pyrimidine-6-carboxylic acid 

Relevant academic research and scientific papers

PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS

Disclosed herein are small molecule modulators hormone receptors, including agonists and antagonists of luteinizing hormone/choriogonadotropin, follicle stimulating hormone and thyroid stimulating hormone receptors. Exemplary disclosed compounds include t

Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: Structure-activity relationships and selective binding patterns

The substituted thieno[2,3-d]pyrimidine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR) and the closely related thyroid-stimulating hormone receptor (TSHR), was fundamentally altered, and the resulting anal

Bicyclic heteroaromatic compounds

A bicyclic heteroaromatic compound according to general formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is (3-8C)cycloalkyl, (2-7C)heterocycloalkyl, (6-14C)aryl or (4-13C)heteroaryl; all optionally substituted with one or